Clinical trial Recruiting at 1 site Observational Ages 22 to 99

Impact of sleep apnea on heart health in patients with atrial fibrillation

Official title: Prospective Study on Obstructive Sleep Apnea and Cardiovascular Outcomes in Patients With Atrial Fibrillation and High Cardiovascular Risk

Run by National University of Singapore · NCT04005508 · Data updated 2026-11-12

This study is testing how sleep apnea affects heart health in people with atrial fibrillation to see if it changes their risk of heart problems.

More Atrial Fibrillation trials

Quick facts

Study typeObservational
Ages22 Years to 99 Years
SexAll
Enrollment1365 (estimated)
SponsorNational University of Singapore
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedJuly 1, 2019
Main results expectedJune 30, 2025
Study endsJune 30, 2028
Registry record updatedJune 12, 2024
Trial IDNCT04005508 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 22 and above with known atrial fibrillation and high cardiovascular risk factors.

Probably not a fit

Patients who are already on regular CPAP treatment for known obstructive sleep apnea may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The POACH study aims to investigate how obstructive sleep apnea (OSA) affects cardiovascular outcomes in patients with atrial fibrillation (AF) who are at high cardiovascular risk. This prospective, observational study will recruit 1365 patients in Singapore, using a home-based sleep study to classify participants based on the presence of OSA. Patients will receive standard AF management, and follow-up assessments will occur every six months for up to two years. The study will also analyze blood samples to measure various metabolites that may provide insights into cardiovascular health.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cardiovascular risks in patients with atrial fibrillation and sleep apnea.

How similar studies have gone: While the relationship between OSA and cardiovascular outcomes is being explored, this specific approach in patients with AF is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 22 or above
2. Known AF, including paroxysmal, persistent or permanent AF
3. High cardiovascular risk, defined as one or more of the following:

   * hypertension
   * diabetes mellitus
   * stroke
   * significant coronary artery disease (at least one stenosis of \>50% diameter in at least one major epicardial artery based on CT or conventional coronary angiography, positive stress test \[treadmill, myocardial perfusion scan, or stress echocardiography\], previous percutaneous coronary intervention, or previous coronary artery bypass surgery)
   * chronic kidney disease (excluding polycystic kidney disease) with an estimated glomerular filtration rate of \<60 ml/min/1.73m2,
   * 10-year risk of cardiovascular disease of 15% or greater on the basis of the Framingham risk score, or
   * age of 75 years or older

Exclusion Criteria:

1. Known OSA on regular CPAP treatment
2. Valvular AF (moderate/severe mitral stenosis or mechanical heart valve)
3. Permanent pacemaker implantation
4. Life expectancy less than 1 year based on concomitant medical conditions
5. Unable to give research consent
6. Pregnant or lactating women

Where it's running

  • Chi-Hang Lee
    Singapore, Singapore
    Recruiting

Study contacts

  • Principal investigator: Chi-Hang R Lee, MD — National University of Singapore
  • Study coordinator: Shalini Lobo, BSc
  • Email: shalilb@nus.edu.sg
  • Phone: 67795555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.